Rifapentine

Specifications

61379-65-5CAS Number

262-743-9EC Number

[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25IUPAC Name

C47H64N4O12Chemical Formula

877 g/molMolecular Weight

RIFAPENTINE; 61379-65-5; Priftin; Rifapentin; Cyclopentylrifampicin; MDL 473; Rifamycin AF/ACPP; Rifapentina; Prifitin; MDL-473; Rifapentinum; DTXSID8041115; 3-(((4-Cyclopentyl-1-piperazinyl)imino)methyl)rifamycin; KTC-1; DL-473; MDL473; XJM390A33U; CHEBI:45304; R-773; [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate; R-77-3; Rifamycin, 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)-; 3-[[(4-Cyclopentyl-1-piperazinyl)imino]methyl]rifamycin; DTXCID6021115; ((7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-((E)-(4-cyclopentylpiperazin-1-yl)iminomethyl)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo(23.3.1.14,7.05,28)triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl) acetate; DL-4-73; RefChem:57295; 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)rifamycin SV; (7S,9Z,11S,12R,13S,14R,15R,16R,17S,18S,21Z)-26-((1E)-((4-cyclopentylpiperazin-1-yl)imino)methyl)-2,15,17,23,27,29-hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6-oxo-8,30-dioxa-24-azatetracyclo(23.3.1.14,7.05,28)triaconta-1(28),2,4,9,19,21,23,25(29),26-nonaen-13-yl acetate; 262-743-9; MFCD00866806; DL 473; Priftin (TN); KTC 1; ANTIBIOTIC DL-473IT; Cyclopentyl rifampin; R 77-3; 3-[N-(4-Cyclopentyl-1-piperazinyl)formimidoyl]rifamycin; C47H64N4O12; (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-3-(((4-Cyclopentyl-1-piperazinyl)imino)methyl)-21-(Acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione; (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-8-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate; DL 473;Cyclopentylrifampicin; 3-(N-(4-Cyclopentyl-1-piperazinyl)formimidoyl)rifamycin; WDZCUPBHRAEYDL-GZAUEHORSA-N; Rifapentinum [Latin]; Rifapentina [Spanish]; Rifampicin S-Na Sodium; Antibiotic DL 473IT; RIFAPENTINE [MI]; RIFAPENTINE [INN]; Rifapentine (USAN/INN); RIFAPENTINE [USAN]; 3-(4-Cyclopentyl-1-piperazinyl)iminomethylrifamycin SV; RIFAPENTINE [VANDF]; CHEMBL1660; RIFAPENTINE [MART.]; UNII-XJM390A33U; SCHEMBL41590; RIFAPENTINE [WHO-DD]; Rifapentine [USAN:INN:BAN]; SCHEMBL29359039; SCHEMBL29913543; GTPL12014; RIFAPENTINE [ORANGE BOOK]; DL473; HMS3713M16; DRG-0283; EINECS 262-743-9; BDBM50248298; MSK158462; AKOS024255723; AR27731; CCG-220467; DB01201; KS-1409; R773; SY102391; C08059; D00879; AB01209744-01; AB01209744-03; AB01209744_04; M000473; R327201; Q3935297; 3-((4-CYCLOPENTYL-1-PIPERAZINYL)IMINO)METHYL)RIFAMYCIN; (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate; [[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-pentahydroxy-methoxy-heptamethyl-dioxo-[?]yl] acetate; RPESynonyms